SAN FRANCISCO, November 16, 2016 /PRNewswire/ --
The global pneumatic nebulizers market was valued atUSD 490.6 million in 2015 and is expected to reach a value of USD 893.9 million by 2025. The expansion is attributed to the increasing geriatric population base along with the growing need for
(Logo: http://photos.prnewswire.com/prnh/20150105/723757 )
Moreover, with the rising rate of hospital admissions and the resultant high expenditure, companies are encouraged to introduce home care devices that enable pre-hospitalization monitoring. Furthermore, the advent of integrated devices has empowered patients and physicians to share and access data on a single platform.
For instance, in March 2016, Philips received 510 (K) clearance for its Care Orchestrator. The cloud-based technology is a clinical management software, which promotes homecare for sleep apnea and respiratory care patients. Moreover, the clinical management system furnishes a single platform combining sleep and respiratory care, providing informatics and workflow intelligence for patients, providers, and payers.
Some of the major players operating include Omron Corporation, Philips Healthcare; PARI Pharma GmbH; GE Healthcare; Allied Healthcare; Becton, Dickinson and Company; Agilent Technologies; Medline Industries, Inc.; and Briggs Healthcare.
Browse full research report with TOC on "Pneumatic Nebulizer Market Analysis By Type (Vented, Breath-Actuated), By Region (North America (U.S. & Canada), Europe (UK & Germany), Asia Pacific (Japan, China & India), Latin America (Brazil & Mexico), Middle East & Africa), And Segment Forecasts To 2025" at: http://www.grandviewresearch.com/industry-analysis/pneumatic-nebulizer-market
Further Key Findings from the Study Suggest:
Browse related reports by Grand View Research:
Grand View Research has segmented the pneumatic nebulizers market by type and region:
Access research insight: http://www.grandviewresearch.com/research-insights/pneumatic-nebulizer-market-increasing-acquisitions-investments-by-industry-players
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Read Our Blogs - grandviewresearch.com/blogs/healthcare
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: firstname.lastname@example.org Web: http://www.grandviewresearch.com
SOURCE Grand View Research, Inc.
Subscribe to our Free Newsletters!
Bubonic plague is an infectious disease caused by the bacteria Yersinia pestis present in rodents ...
Steroids are miracle drugs but have to be used with caution. Some steroids are illegal to use, ...
Abruptio placenta is a serious but rare complication of pregnancy where a separation of placenta ...View All